# Novel Diagnostics for Early Lyme Disease

> **NCT03963635** · — · UNKNOWN · sponsor: **MicroB-plex, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Lyme Disease

## Interventions

- **DIAGNOSTIC_TEST:** MicroB-plex Lyme Immunoassay

## Key facts

- **NCT ID:** NCT03963635
- **Lead sponsor:** MicroB-plex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963635, "Novel Diagnostics for Early Lyme Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03963635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*